Open Access Highly Accessed Pre-publication history

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands

Tjalke A Westra*, Irina Stirbu-Wagner, Sara Dorsman, Eric D Tutuhatunewa, Edwin L de Vrij, Hans W Nijman, Toos Daemen, Jan C Wilschut and Maarten J Postma

BMC Infectious Diseases 2013, 13:75  doi:10.1186/1471-2334-13-75

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 22 May 2012
Resubmission - Version 2 Manuscript 29 May 2012
Resubmission - Version 3 Manuscript 31 May 2012
Resubmission - Version 4 Manuscript 06 Jun 2012
Reviewer's Report Philippe Beutels 22 Jul 2012
Reviewer's Report Walter Ricciardi 09 Aug 2012
Reviewer's Report Eduardo Lazcano-Ponce 14 Aug 2012
Resubmission - Version 5 Manuscript Author's comment 19 Oct 2012
Reviewer's Report Walter Ricciardi 18 Nov 2012
Resubmission - Version 6 Manuscript Author's comment 17 Dec 2012
Resubmission - Version 7 Manuscript 17 Dec 2012
Editorial acceptance 25 Jan 2013
Published 07 Feb 2013